Bone marrow derived mesenchymal stem cells（Karolinska University Hospital）

N/A

Report date: 2026/01/28 20:01:42

Base Information

Drug NameBone marrow derived mesenchymal stem cells（Karolinska University Hospital）
Drug Alias NameKI-MSC-PL-204MSC-KI-PL-204
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHoarsenessDysphoniaAphonia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKarolinska University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesKarolinska University Hospital
Inactive CompaniesN/A
Active IndicationsHoarsenessDysphoniaAphonia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A